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The following changes were made to the article by Creager MA, Belkin M, Bluth EI, et al., “2012 ACCF/AHA/ACR/
SCAI/SIR/STS/SVM/SVN/SVS Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease:
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data
Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease),” as it
appears in the January 17, 2012, issue of the Journal (J Am Coll Cardiol 2012;59:294–357; doi: 10.1016/j.jacc.2011.10.860)
after it published ahead of print December 6, 2011:
The Society for Vascular Surgery (SVS) endorsed the document December 14, 2011, after it published ahead of print on
December 6, 2011. SVS approval was noted on p. 294 and p. 304. The document title was appended with “SVS” throughout
the article.
In Section 2.2, Relationships With Industry and Other Entities, the last paragraph (p. 297), the following sentence was
deleted, “In addition, to ensure complete transparency, writing committee members’ comprehensive disclosure information—
including relationships not pertinent to this document—is available online as a supplement to this document.” The associated
data supplement was deleted from the Journal Web site, which read:
It is the policy of the American College of Cardiology Foundation and the American Heart Association to make available online
complete disclosure of relationships with industry and other entities of the writing committee, including relationships not pertinent
to a document. Because the “2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN Key Data Elements and Definitions for
Peripheral Atherosclerotic Vascular Disease” document was initiated before this policy was enacted, comprehensive disclosures were
not collected. See Appendix 1 of the article for the relationships of writing committee members with industry and other entities that
were reported by authors to be relevant to the document.
In the Appendix 2 footnote, the last paragraph, the definition of “SVS” was corrected from “Society of Vascular Surgeons”
to “Society for Vascular Surgery.”
doi:10.1016/j.jacc.2012.01.004
Nannenberg EA, Michels M, Christiaans I, et al. Mortality Risk of Untreated Myosin-Binding Protein C–Related
Hypertrophic Cardiomyopathy: Insight Into the Natural History. J Am Coll Cardiol 2011;58:2406–14.
There is an error in the Results section of the Abstract:
In the small families, the SMR was increased (SMR 3.2 [95% CI: 2.3 to 4.3]) and excess mortality was observed between 10 and
39 years (SMR 3.2 [95% CI: 2.3 to 4.3]) and 50 and 59 years (SMR 1.9 [95% CI: 1.4 to 2.5]).
should have read:
In the small families, the SMR was increased (SMR 1.5 [95% CI: 1.3 to 1.6]) and excess mortality was observed between 10 and
39 years (SMR 3.2 [95% CI: 2.3 to 4.3]) and 50 and 59 years (SMR 1.9 [95% CI: 1.4 to 2.5]).
Furthermore, in Table 1 the mutation ‘c.3258dup (p.Lys1087GlufsX62)’ should have been ‘c.3257_3258dup
(p.Lys1087GlyfsX103).’
The authors apologize for these errors.
doi:10.1016/j.jacc.2012.01.006
